Total Payments
$5,221
2024 Payments
$1,463
Companies
38
Transactions
280
Medicare Patients
596
Medicare Billing
$54,472
Payment Breakdown by Category
Food & Beverage$5,067 (97.0%)
Education$154.58 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,067 | 276 | 97.0% |
| Education | $154.58 | 4 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,019 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $746.91 | 27 | $0 (2024) |
| PFIZER INC. | $516.23 | 47 | $0 (2024) |
| Janssen Biotech, Inc. | $412.87 | 25 | $0 (2023) |
| UCB, Inc. | $323.99 | 14 | $0 (2023) |
| Horizon Therapeutics plc | $275.75 | 12 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $232.36 | 11 | $0 (2023) |
| Lilly USA, LLC | $184.36 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $162.98 | 9 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $162.86 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,463 | 95 | ABBVIE INC. ($492.09) |
| 2023 | $1,475 | 71 | AstraZeneca Pharmaceuticals LP ($298.75) |
| 2022 | $1,274 | 63 | ABBVIE INC. ($218.20) |
| 2021 | $1,009 | 51 | AbbVie Inc. ($172.64) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: PAIN | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: PAIN | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: PAIN | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Gastroenterology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: PAIN | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 309 | 448 | $106,905 | $30,467 |
| 2022 | 4 | 180 | 296 | $62,964 | $19,547 |
| 2020 | 3 | 107 | 163 | $27,968 | $4,458 |
Total Patients
596
Total Services
907
Medicare Billing
$54,472
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 188 | $49,052 | $14,871 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 206 | $37,746 | $10,000 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 39 | $13,882 | $4,062 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,225 | $1,533 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 246 | $45,264 | $14,300 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 20 | $7,280 | $2,266 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $6,640 | $1,786 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 14 | $3,780 | $1,195 | 31.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 50 | 86 | $15,824 | $2,435 | 15.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 46 | 66 | $9,174 | $1,247 | 13.6% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 11 | 11 | $2,970 | $775.79 | 26.1% |
About Holly Ackermann, FNP
Holly Ackermann, FNP is a Rheumatology healthcare provider based in Festus, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2018. The National Provider Identifier (NPI) number assigned to this provider is 1003303389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Holly Ackermann, FNP has received a total of $5,221 in payments from pharmaceutical and medical device companies, with $1,463 received in 2024. These payments were reported across 280 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,067).
As a Medicare-enrolled provider, Ackermann has provided services to 596 Medicare beneficiaries, totaling 907 services with total Medicare billing of $54,472. Data is available for 3 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Nurse Practitioner, Family
- Location Festus, MO
- Active Since 04/22/2018
- Last Updated 11/28/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1003303389
Products in Payments
- TREMFYA (Drug) $485.39
- SAPHNELO (Biological) $456.83
- VRAYLAR (Drug) $369.91
- XELJANZ (Drug) $331.94
- RINVOQ (Biological) $323.03
- KRYSTEXXA (Biological) $275.75
- Cimzia (Drug) $233.99
- NURTEC ODT (Drug) $174.44
- BENLYSTA (Biological) $162.98
- TALTZ (Drug) $152.25
- QULIPTA (Drug) $125.37
- FARXIGA (Drug) $124.53
- COSENTYX (Biological) $114.12
- PURIFIED CORTROPHIN GEL (Drug) $113.92
- BREZTRI (Drug) $99.00
- RENFLEXIS (Drug) $86.87
- UBRELVY (Drug) $85.59
- Kineret (Drug) $83.10
- XIFAXAN (Drug) $72.30
- SIMPONI ARIA (Biological) $68.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.